Can-Fite to Harness Artificial Intelligence to Develop Novel Anti-Cancer Drugs
Go back to Can-Fite to Harness Artificial Intelligence to Develop Novel Anti-Cancer Drugs| CAN-FITE BIOPHARMA LTD. (NYSE: CANF) | Delayed: 2.24 +0.08 (3.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.16 | 52 Week High | $3.89 | |||
| Open | $2.17 | 52 Week Low | $1.85 | |||
| Day High | $2.28 | P/E | N/A | |||
| Day Low | $2.16 | EPS | $0.00 | |||
| Volume | 11,044 | |||||
| CAN-FITE BIOPHARMA LTD. (NYSE: CANF) | Delayed: 2.24 +0.08 (3.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.16 | 52 Week High | $3.89 | |||
| Open | $2.17 | 52 Week Low | $1.85 | |||
| Day High | $2.28 | P/E | N/A | |||
| Day Low | $2.16 | EPS | $0.00 | |||
| Volume | 11,044 | |||||

